AstraZeneca, Oxford University COVID-19 vaccine shows robust immune responses in Phase I/II trial
Interim data shows strong antibody and T-cell responses in all evaluated participants
Interim data shows strong antibody and T-cell responses in all evaluated participants
Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms
xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing
Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
From Monday, July 20: Join world-leading clinical scientists and healthcare professionals online - free to attend
The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases
Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine
The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand
This unique feature is offered as a package that allows the user to measure polarization spectra in either transmission or reflectance modes
Starts Monday, July 6. Register for free today to stay informed on the latest techniques and technologies for COVID-19 and infectious disease research
Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management
The platform aims to deliver rapid and automated processing of human blood and blood products to obtain purified populations of immune cells
binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein
Providing researchers with expanded capabilities in interrogating the tissue microenvironment
The partnership aims to provide accessible solutions for labs involved in COVID-19 testing
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
First subjects recently administered immunizations in two studies of 20-valent pneumococcal conjugate vaccine candidate in infants; a pentavalent meningococcal vaccine candidate in adolescents; and a respiratory syncytial virus vaccine candidate in pregnant women
The partnership aims to accelerate the commercialization of enzymatic DNA synthesis
Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019